ALEXANDRIA, Va., June 18 -- United States Patent no. 12,326,451, issued on June 10, was assigned to INSTITUT PASTEUR (Paris).
"Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics" was invented by Sylvie Van Der Werf (Paris), Nicolas Escriou (Paris), Caroline Demeret (Paris), Stephane Petres (Paris), Pierre Lafaye (Paris) and Jacques Bellalou (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the diagnosis of a SARS-associated coronavirus, such as a SARS-CoV-2 infection and SARS-CoV-1 infection, using the N_SARS-CoV-1 and N_SARS-CoV-2 proteins and antibodies binding to these proteins. The invention reagents, methods and kits for the detection of a SARS-assoc...